Therapeutic approaches in hereditary angioedema
- PMID: 21279474
- DOI: 10.1007/s12016-011-8254-2
Therapeutic approaches in hereditary angioedema
Abstract
Hereditary angioedema (HAE) is characterized by acute attacks of edema with multiple localizations, the laryngeal angioedema being the most potentially lethal. In HAE, C1-INH impairments cause episodic increase in kallikrein activity leading to attacks of angioedema. Several therapies have recently become available to treat or to prevent HAE attacks, and others are under evaluation for this indication. Plasma-derived C1-INH, bradykinin receptor antagonists (icatibant), kallikrein inhibitors (ecallantide), or recombinant C1-INH is authorized on the market for HAE attack therapy or prophylaxis. Some of these compounds can be used exclusively to treat HAE attacks, whereas others can also be used as prophylactic therapies. Such therapies, although not available worldwide, can improve disease outcome due to their different mechanisms of action.
Similar articles
-
Hereditary angioedema therapies in the United States: movement toward an international treatment consensus.Clin Ther. 2012 Mar;34(3):623-30. doi: 10.1016/j.clinthera.2012.02.003. Epub 2012 Mar 2. Clin Ther. 2012. PMID: 22386830
-
New therapies for hereditary angioedema: disease outlook changes dramatically.J Allergy Clin Immunol. 2008 Jan;121(1):272-80. doi: 10.1016/j.jaci.2007.11.019. J Allergy Clin Immunol. 2008. PMID: 18206518
-
Treatment of Hereditary Angioedema.J Investig Allergol Clin Immunol. 2021 Feb;31(1):1-16. doi: 10.18176/jiaci.0653. J Investig Allergol Clin Immunol. 2021. PMID: 33602658 Review.
-
Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).Expert Rev Clin Immunol. 2015 Mar;11(3):319-27. doi: 10.1586/1744666X.2015.1012502. Epub 2015 Feb 10. Expert Rev Clin Immunol. 2015. PMID: 25669442 Review.
-
Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy.J Clin Immunol. 2018 Oct;38(7):810-815. doi: 10.1007/s10875-018-0553-4. Epub 2018 Oct 2. J Clin Immunol. 2018. PMID: 30280305
Cited by
-
SARS-CoV-2 receptor is co-expressed with elements of the kinin-kallikrein, renin-angiotensin and coagulation systems in alveolar cells.Sci Rep. 2020 Nov 11;10(1):19522. doi: 10.1038/s41598-020-76488-2. Sci Rep. 2020. PMID: 33177594 Free PMC article.
-
Interactions between coagulation and complement--their role in inflammation.Semin Immunopathol. 2012 Jan;34(1):151-65. doi: 10.1007/s00281-011-0280-x. Epub 2011 Aug 3. Semin Immunopathol. 2012. PMID: 21811895 Free PMC article. Review.
-
Hereditary angioedema: what the gastroenterologist needs to know.Clin Exp Gastroenterol. 2014 Nov 20;7:435-45. doi: 10.2147/CEG.S50465. eCollection 2014. Clin Exp Gastroenterol. 2014. PMID: 25429234 Free PMC article. Review.
-
Complement activation and inhibition in wound healing.Clin Dev Immunol. 2012;2012:534291. doi: 10.1155/2012/534291. Epub 2012 Dec 30. Clin Dev Immunol. 2012. PMID: 23346185 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources